10333912

Source:http://linkedlifedata.com/resource/pubmed/id/10333912

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011860, umls-concept:C0025598, umls-concept:C0030705, umls-concept:C0246689, umls-concept:C0332307, umls-concept:C1280500, umls-concept:C1883712, umls-concept:C2587213
pubmed:issue	1
pubmed:dateCreated	1999-7-13
pubmed:abstractText	To compare the effect of repaglinide in combination with metformin with monotherapy of each drug on glycemic control in patients with type 2 diabetes.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10333912-18405794
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Carbamates, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Metformin, http://linkedlifedata.com/resource/pubmed/chemical/Piperidines, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/repaglinide
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0149-5992
pubmed:author	pubmed-author:BoyagesSS, pubmed-author:CarterJJ, pubmed-author:ColagiuriSS, pubmed-author:DonnellyTT, pubmed-author:HopkinsHH, pubmed-author:KidsonWW, pubmed-author:MoffittPP, pubmed-author:MosesRR, pubmed-author:SlobodniukRR
pubmed:issnType	Print
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	119-24
pubmed:dateRevised	2008-10-1
pubmed:meshHeading	pubmed-meshheading:10333912-Australia, pubmed-meshheading:10333912-Blood Glucose, pubmed-meshheading:10333912-C-Peptide, pubmed-meshheading:10333912-Carbamates, pubmed-meshheading:10333912-Cholesterol, pubmed-meshheading:10333912-Cholesterol, HDL, pubmed-meshheading:10333912-Cholesterol, LDL, pubmed-meshheading:10333912-Diabetes Mellitus, Type 2, pubmed-meshheading:10333912-Double-Blind Method, pubmed-meshheading:10333912-Drug Therapy, Combination, pubmed-meshheading:10333912-Fasting, pubmed-meshheading:10333912-Fatty Acids, Nonesterified, pubmed-meshheading:10333912-Female, pubmed-meshheading:10333912-Hemoglobin A, Glycosylated, pubmed-meshheading:10333912-Humans, pubmed-meshheading:10333912-Hypoglycemic Agents, pubmed-meshheading:10333912-Male, pubmed-meshheading:10333912-Metformin, pubmed-meshheading:10333912-Middle Aged, pubmed-meshheading:10333912-Piperidines, pubmed-meshheading:10333912-Triglycerides
pubmed:year	1999
pubmed:articleTitle	Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
pubmed:affiliation	Department of Endocrinology, Illawarra Regional Hospital, Wollongong, Australia. robert_moses@uow.edu.au
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study